Page 54 - Syndipharma

Production Lines:
At the present moment, our company has the capability of manufacturing tablets and capsules directly, as well as
producing them through contract manufacturing, and a line for producing Nitroglycerin Granules as demonstrated in
Table 2. Our main priority at Dorsa Pharmaceutical Co. is expanding the company’s activities by exporting manufac- IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
tured products overseas and increasing our market share in the country.

Premier Partners:
Recpharma Co. (API manufacturing), Tavan Lab. Institute (Accredited by MOH to carry
bio- equivalency tests for other pharma companies), Dorsa University and Vista Pars Co. (Commercial company)

Certificates:
GMP Certificate by Iranian FDA for General Solid Dosage Forms issued based on new PIC/S guidelines - June 2015
(Iran MOH is a new official member of PIC/S since 2018)
cGMP Certificate by Iranian FDA for Pharmaceutical Raw Material issued based on new PIC/S guidelines - August
2015
• ISO9001: 2008 • ISO14001: 2004 •OHSAS18001: 2007 •MITEC, ICS Group International: 2015

Therapeutic Groups and Pharmaceuticals with Capacity for Exports:
We have learned to provide high quality pharmaceutical products, through a decade of pursuing to produce highly
purified API and finished product. It should be mentioned that Dorsa Pharmaceutical produces Nitroglycerin API in
our production line from the very first step.
We are reliable, long-term partner in Iranian pharma industry. Together, we can deliver the right solutions at the right
time, building long term relationships with our partner for mutual benefits
As especial field of interest, we are looking for sustainability by pursuing economic performance, environmental
quality and social responsibility, which can benefit the most for our partners benefiting from world class quality and
competitive prices.

Target Countries for Exports:
- India - ASEAN countries - Eastern Europe - Russia - CIS countries - MENA countries

Contact details:
Dorsa Bldg., No.1, Khajoo St., Salehi Blvd., Jenah Expy., Azadi Sq., Tehran, Iran.
Tel: +98 (21) 546 12000 Fax +98 (21) 66008533
Website: www.dorsadarou.com
Email: info@dorsadarou.com

Product List
“Table 1”

Type Product Dosage Form & Indication Status
Strength

Dorocontin ® Nitroglycerin 2.6 & 6.4 mg ER Angina Pectoris, acute & chronic In Market
Tablets
(treatment & prophylaxis)
VASODILATORS
USED IN CARDIAC Lipi-cut ® Atorvastatin 20 & 40 mg Tablets Hyperlipidemia (treatment) In Market
DISEASES

- Losartan 25 & 50 mg Tablets Hypertension (treatment) In Market

53
you can find the rest of the product list on page 236